Special purpose acquisition company
Abpro to go public via SPAC merger with Atlantic Coastal, raising funds for its HER2xCD3 bispecific and COVID-19 program
Anika Sharma
Abpro is making a return to the public market after a five-year hiatus, this time teaming up with Atlantic Coastal ...
Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments
Anika Sharma
Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...
Nobel Prize Winner’s Biotech Company Escapes the Graveyard with SPAC
Anika Sharma
Reviving a Silent Spell: Celixir, a UK-based cell therapy biotech, emerges from the shadows with a transformative move. Following a ...
